辨证治疗风湿性心瓣膜并心力衰竭临床分析

Clinical Observation on Treatment of Rheumatic Heart Disease with Syndrome Differentiation

目的探讨辨证治疗风湿性心瓣膜并心力衰竭的临床效果及价值。方法以该院于2015年1—12月间收治的40例风湿性心瓣膜并心力衰竭患者为研究对象,按照时间顺序将其分为两组,采用中医辨证治疗的观察组(20例)和采用西药常规治疗的对照组(20例),观察两组患者的治疗情况和PASI评分变化情况,判断两种治疗方法的临床效果。结果观察组的治疗总有效率为95%,明显高于对照组75%,治疗前后观察组的PASI评分分别为(7.3±2.7)分、(2.3±1.4)分,和对照组相比变化更加明显,两组差异有统计学意义(P<0.05)。结论对风湿性性瓣膜并心力衰竭患者实施中医辨证治疗,效果显著,安全性高,值得推广和应用。

Objective To investigate Differential Treatment of rheumatic valvular heart failure and clinical effect and value. Methods In our hospital in January 2015 to December 2015 were treated 40 cases of rheumatic heart valve and heart failure patients for the study, in chronological order will be divided into two groups, the use of TCM treatment ob- servation group （20 cases） and the use of conventional western medicine treatment group （20 cases）, treatment and changes in PASI scores were observed, to determine the clinical effect of two treatment approaches. Results The observation group total effective rate was 95%, significantly higher than 75%, before and after treatment in the observation group were PASI score （7.3 ± 2.7）points, （2.3 ± 1.4）points, and the control group compared to the more obvious changes The difference was statistically significant （P 〈0.05）. Conclusion Patients with heart failure and rheumatic valvular imple- ment TCM treatment, the effect is significant, safe, worthy of promotion and application.